Methods, compositions and components for CRISPR-CAS9 editing of TGFBR2 in T cells for immunotherapy

• 收藏
• 分享

专利权人:

Editas Medicine, Inc.;Juno Therapeutics, Inc.

发明人:

BURLEIGH, Stephen Michael,CHIN, Melissa,HARBINSKI, Fred,NYE, Christopher Heath,SATHER, Blythe D.,VONG, Queenie,WELSTEAD, Gordon Grant,WILSON, Chris

申请号：

AU2018358250

公开号：

AU2018358250A1

申请日:

2018.11.01

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

CRISPR/CAS-related genome editing systems, compositions and methods for targeting the TGFBR2 locus, as well as cells edited using these systems, compositions and methods are provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/